Study Overview: This study looks at whether a new drug called ribupatide can help people with obesity lose weight better than another drug called semaglutide or a placebo (a substance with no active medicine). Ribupatide and semaglutide are both given through a shot under the skin once a week.
Eligibility: To be part of this study, you must have a Body Mass Index (BMI) of 35 or higher. BMI is a number that shows if you have a healthy weight for your height. You also need to have tried to lose weight with diet or exercise in the last 6 months without success. If you have diabetes or take certain medications that affect your weight, you cannot join.
Key Points:
- The study involves weekly injections for treatment.
- Participants must not have diabetes and must meet other health requirements.
- Risks include potential side effects from the medication, and eligibility is strict.
How understandable was the trial content above?
Hard to understand
Easy to understand